Research in Social and Administrative Pharmacy
Volume 1, Issue 4 , Pages 508-525 , December 2005

The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes

  • Jingdong Chao, Ph.D.

      Affiliations

    • Department of Health Outcomes, Aventis Pharmaceuticals, Bridgewater, NJ, USA
    • At the time of this study, Drs Chao and Taylor were affiliated with the Department of Social and Administrative Sciences at the University of Michigan College of Pharmacy.
    • ,
  • David P. Nau, Ph.D.

      Affiliations

    • Department of Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, MI 48109-1065, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 734 615 9083; fax: +1 734 615 8171.
    • ,
  • James E. Aikens, Ph.D.

      Affiliations

    • Department of Family Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
    • Department of Psychiatry, University of Michigan School of Medicine, Ann Arbor, MI, USA
    • ,
  • Stephanie D. Taylor, Ph.D.

      Affiliations

    • Department of Health Outcomes Research, Merck & Co, Inc, Whitehouse Station, NJ, USA
    • At the time of this study, Drs Chao and Taylor were affiliated with the Department of Social and Administrative Sciences at the University of Michigan College of Pharmacy.

References 

  1. Genuth S, Eastman R, Kahn R, et al. Implications of the United Kingdom prospective diabetes study. Diabetes Care. 2003;26:S28–S32
  2. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218–1224
  3. Cox DJ, Gonder-Frederick L. Major developments in behavioral diabetes research. J Consult Clin Psychol. 1992;60:628–638
  4. Guillausseau P. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab. 2003;29:79–81
  5. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958–2971
  6. Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10:144–151
  7. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–1078
  8. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278–3285
  9. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107
  10. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154–2160
  11. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504–511
  12. Wing RR, Phelan S, Tate D. The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res. 2002;53:877–881
  13. Kilbourne AM, Reynolds CF, Good CR, et al. How does depression influence diabetes medication adherence in older patients?. Am J Geriatr Psychiatry. 2005;13:202–210
  14. Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23:413–418
  15. Lewis KS, Jennings AM, Ward JD, Bradley C. Health belief scales developed specifically for people with tablet-treated type 2 diabetes. Diabet Med. 1990;7:148–155
  16. Padgett DK. Correlates of self-efficacy beliefs among patients with non-insulin dependent diabetes mellitus in Zagreb, Yugoslavia. Patient Educ Counsel. 1991;18:139–147
  17. Talbot F, Nouwen A, Gingras J, Gosselin M, Audet J. The assessment of diabetes-related cognitive and social factors: the Multidimensional Diabetes Questionnaire. J Behav Med. 1997;20:291–312
  18. Nagasawa M, Smith MC, Barnes JH, Fincham JE. Meta-analysis of correlates of diabetes patients' compliance with prescribed medications. Diabetes Educ. 1990;16:192–200
  19. Strecher VJ, Rosenstock IM. The health belief model. In:  Glanz K,  Lewis FM,  Rimer BK editor. Health Behavior and Health Education. 2nd ed.. San Francisco: Jossey-Bass Inc; 1997;p. 41–59
  20. Nau DP, Ried LD, Lipowski EE, et al. A perceived value model for explaining patients' intentions to continue use of pharmaceutical care services. J Pharm Market Manag. 2001;14:63–80
  21. Ronis DL. Conditional health threats: health beliefs, decisions, and behaviors among adults. Health Psychol. 1992;11:127–134
  22. National Committee for Quality Assurance . HEDIS 2001 Technical Specifications. Washington, DC: National Committee for Quality Assurance; 2001;102–108
  23. Glasgow RE, Wilson W, McCaul KD. Regimen adherence: a problematic construct in diabetes research. Diabetes Care. 1985;8:300–301
  24. Cerkoney KA, Hart LK. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care. 1980;3:594–598
  25. Given GW, Given BA, Gallin RS, Condon JW. Development of scales to measure beliefs of diabetic patients. Res Nurs Health. 1983;6:127–141
  26. Harris R, Linn MW, Skyler JS, Sandifer R. Development of the diabetes health belief scale. Diabetes Educ. 1987;13:292–297
  27. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24
  28. Bandura A. Self-efficacy: toward a unifying theory of behavior change. Psychol Rev. 1977;84:191–215
  29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613
  30. Corson K, Gerrity MS, Dobscha SK. Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item. Am J Manag Care. 2004;10:839–845
  31. Hintikka J, Pesonen T, Saarinen P, Tanskanen A, Lehtonen J, Viinamaki H. Suicidal ideation in the Finnish general population. A 12-month follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2001;36:590–594
  32. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74
  33. Liang J, Lawrence RH, Bennett JM, Whitelaw NA. Appropriateness of composites in structural equation models. J Gerontol. 1990;45:52–59
  34. Raykov T, Tomer A, Nesselroade JR. Reporting structural equation modeling results in Psychology and Aging: some proposed guidelines. Psychol Aging. 1991;6:499–503
  35. Boomsma A. Reporting analyses of covariance structures. Structural Equation Modeling. 2000;7:461–483
  36. Kline RB. Principles and Practice of Structural Equation Modeling. New York: Guilford Press; 1979;
  37. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124–133
  38. Beck AT, Rush AJ, Shaw BF, Emery G. An overview. In:  Beck AT,  Rush AJ,  Shaw BF,  Emery G editor. Cognitive Therapy of Depression. New York: Guilford Press; 1979;p. 1–33[chapter 1]
  39. Abramson LY, Metalsky GI, Alloy LB. Hopelessness depression: a theory-based subtype of depression. Psychol Rev. 1989;96:358–372
  40. National Institute of Mental Health. Anxiety Disorders. NIH Publication No. 02-3879. 2002.
  41. Abraham C, Clift S, Grabowski P. Cognitive predictors of adherence to malaria prophylaxis regimens on return from a malarious region: a prospective study. Soc Sci Med. 1999;48:1641–1654
  42. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–1412
  43. Gonder-Frederick LA, Clarke WL, Cox DJ. The emotional, social, and behavioral implications of insulin-induced hypoglycemia. Semin Clin Neuropsychiatry. 1997;2:57–65
  44. Brown CM, Segal R. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives. Soc Sci Med. 1996;43:903–917
  45. Horne R. Treatment perceptions and self-regulation. In:  Cameron LD,  Leventhal H editor. The Self-regulation of Health and Illness Behaviour. New York: Routledge; 2003;p. 138–153
  46. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25:246–252
  47. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002;53:859–863
  48. Lustman PJ, Clouse RE, Carney RM. Depression and the reporting of diabetes symptoms. Int J Psychiatry Med. 1988;18:295–303
  49. Irvine AA, Cox D, Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol. 1992;11:135–138
  50. Browne DL, Avery L, Turner BC, Kerr D, Cavan DA. What do patients with diabetes know about their tablets?. Diabetes Med. 2000;17:528–531
  51. Ainsworth P. What is depression?. In:  Ainsworth P editors. Understanding Depression. Jackson, Miss: University Press of Mississippi; 2000;p. 3–22
  52. Baranowski T, Perry CL, Parcel GS. How individuals, environments, and health behavior interact: social cognitive theory. In:  Glanz K,  Lewis FM,  Rimer BK editor. Health Behavior and Health Education. 2nd ed.. San Francisco: Jossey-Bass Inc; 1997;p. 153–178
  53. Schwarzer R. Self-efficacy in the adoption and maintenance of health behaviors: theoretical approaches and a new model. In:  Schwarzer R editors. Self-Efficacy: Thought Control of Action. New York: Taylor&Francis; 1992;p. 217–244
  54. Aljasem LI, Peyrot M, Wissow L, Rubin RR. The impact of barriers and self-efficacy on self-care behaviors in type 2 diabetes. Diabetes Educ. 2001;27:393–404
  55. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31:S123–S127
  56. Brus H, van de Laar M, Taal E, Rasker J, Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Counsel. 1999;36:57–64
  57. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:S136–S139
  58. Connell CM, Davis WK, Gallant MP, Sharpe PA. Impact of social support, social cognitive variables and perceived threat on depression among adults with diabetes. Health Psychol. 1994;13:263–273

PII: S1551-7411(05)00096-3

doi: 10.1016/j.sapharm.2005.09.002

Research in Social and Administrative Pharmacy
Volume 1, Issue 4 , Pages 508-525 , December 2005

Article Tools

* Image Usage & Resolution